Court of Justice (Eighth Chamber) 14 November 2013, C-617/12 (Astrazeneca AB v Comptroller General of Patents, Designs and Trade Marks.)

ORDER OF THE COURT (Eighth Chamber) 14 November 2013 ( *1 ) ‛Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 13(1) — Concept of ‘first authorisation to place [a product] on the market in the Community’ — Authorisation issued by the Swiss Institute for Medicinal Products (Swissmedic) — Automatic recognition in Liechtenstein —